Asthma Drugs Flashcards
Inhaled Corticosteroids (ICS)
Ex: Mometasone, Budesonide, Fluticasone
MOA: Activates GRs (steroid receptors) on many different immune cells (including mast cells)
- also upregulates beta-2 receptors on bronchiole smooth muscle
- Days to weeks for maximal effect (genomic effects?)
- not effective for asthma attacks
AEs: Dysphonia (thins vocal cords) Oral thrush (fungal infections)
Higher dose –> increased systemic effects
Osteoporosis
Skin thinning
increased blood glucose
increased blood pressure
decreased growth velocity in kids
Beta-2 Agonists
Ex: Albuterol: short-acting (SABA); Salmeterol: long acting (LABA)
(Inhaled)
MOA: agonist to beta-2 adrenergic receptor on bronchiole smooth muscle –> bronchodilation
AEs: Skeletal muscle tremor (stimulation of noninnervated beta-2 on SKM)
Hypokalemia (stimulation of noninnervated beta-2 on SKM)
CNS: Anxiety
Cardiac stimulation of beta-1 –> tachycardia, palpitations (not 100% selective for beta-2)
Prolonged QTc (Kr blockade)
Overuse –> diminished effect (minimized if combined with ICS)
Clinical Trials:
LABA monotherapy –> increased asthma-related death
*Cannot use LABA as monotherapy for asthma
(must combine with ICS)
Leukotriene Modifiers 1
Ex: Montelukast, Zafirlukast
(Oral)
MOA: block CysLT1 receptors –> bronchodilation
–> decreases inflammation
AEs: Neuropsychiatric
Leukotriene Modifiers 2
Ex: Zileuton
(Oral)
MOA: block LOX –> synthesis of LTs
–> bronchodilation –> inflammation
AEs: Neuropychiatric
Hepatotoxicity (need to monitor LFTs)
Methylxanthines
Ex: Theophylline
(Oral)
MOA: block PDE –> increases cAMP/PKA effects block adenosine receptors other effects (immunological and other)
Bronchodilation, decreases inflammation
AEs:
Tachycardia
Nausea/vomiting
Headache
Seizures
Hypokalemia
Cromolyns
Ex: Cromolyn
(inhaled)
MOA: inhibits mast cells (takes weeks for max effect)
*prevention prior to exposure or exercise
Bronchodilation, decreased inflammation
AEs: minimal
Muscarinic Antagonists
Ex:
Ipratropium (short-acting- “SAMA”)
Tiotropium (long-acting- “LAMA”)
(Inhaled)
MOA: nonselective muscarinic antagonist
block M3 on bronchiole smooth muscle g bronchodilation
AEs: confusion
drowsiness
attacks of narrow angle (“angle-closure”)
glaucoma
decreased accommodation for near vision
(cycloplegia)
xerostomia
tachycardia
constipation
urinary retention
anhidrosis -> increased body temp -> reflex
vasodilation
Anti-IgE Antibodies
Ex: Omalizumab
(SQ injections)
MOA: Antibody to IgE –> prevents binding of IgE to receptors on mast cells –> decreases activation of mast cells –> bronchodilation
–> decreases inflammation
AEs: Pain/burning at injection site
allergic reaction
Drug-Induced Asthma
- NSAIDs –> increases LT synthesis
- Beta blockers (nonselective > beta-1 selective) –> block beta-2 mediated
bronchodilation - Muscarinic agonists, AChEIs
–> Stimulation of M3 on bronchiole smooth muscle